CME Group Inc.
CME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,537,600 | $1,692,000 | $1,642,300 | $1,525,300 |
| % Growth | -9.1% | 3% | 7.7% | – |
| Cost of Goods Sold | $237,600 | $221,600 | $206,700 | $220,800 |
| Gross Profit | $1,300,000 | $1,470,400 | $1,435,600 | $1,304,500 |
| % Margin | 84.5% | 86.9% | 87.4% | 85.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $36,700 | $37,400 | $28,500 | $33,900 |
| SG&A Expenses | $36,700 | $37,400 | $28,500 | $33,900 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $290,700 | $303,700 | $299,100 | $323,500 |
| Operating Expenses | $327,400 | $341,100 | $327,600 | $357,400 |
| Operating Income | $972,600 | $1,129,300 | $1,108,000 | $947,100 |
| % Margin | 63.3% | 66.7% | 67.5% | 62.1% |
| Other Income/Exp. Net | $204,400 | $201,000 | $136,800 | $149,500 |
| Pre-Tax Income | $1,177,000 | $1,330,300 | $1,244,800 | $1,096,600 |
| Tax Expense | $269,000 | $305,200 | $288,600 | $222,000 |
| Net Income | $908,000 | $1,012,200 | $956,200 | $874,600 |
| % Margin | 59.1% | 59.8% | 58.2% | 57.3% |
| EPS | 2.49 | 2.81 | 2.63 | 2.4 |
| % Growth | -11.4% | 6.8% | 9.6% | – |
| EPS Diluted | 2.49 | 2.81 | 2.62 | 2.4 |
| Weighted Avg Shares Out | 359,653 | 359,636 | 359,613 | 359,389 |
| Weighted Avg Shares Out Dil | 360,330 | 360,297 | 360,227 | 360,050 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $44,000 | $44,000 | $41,700 | $40,700 |
| Depreciation & Amortization | $82,600 | $83,400 | $82,500 | $83,400 |
| EBITDA | $1,303,600 | $1,457,700 | $1,369,000 | $1,220,700 |
| % Margin | 84.8% | 86.2% | 83.4% | 80% |